Sort by
Refine Your Search
-
studies, including experimental planning, data acquisition in collaboration with imaging colleagues, quantitative analysis and integration with behavioural findings. Perform and develop molecular and tissue
-
Materials Development (Lab4DMade). A central aim of the project, and of this position, is to develop local strain analysis tools for the state of-the-art laboratory 4D X-ray micro-beam diffraction technique
-
colleagues in the group and external partners in Denmark and abroad. You will work with the design and execution of research studies, the analysis and interpretation of data, and the dissemination of results
-
for downstream sequencing and imaging. Performing MALDI mass spectrometry and spatial transcriptomics to characterize biological niches within mouse and human tissue samples. Performing quantitative imaging
-
. Experience with one or more of the following will be considered an advantage: RNA sequencing or other omics technologies, including data analysis; advanced microscopy or image analysis; renal physiology
-
total scattering, WAXS and SAXS, imaging, and femtosecond X ray diffraction to probe structure and dynamics in real time under device relevant conditions. Target facilities include DESY, MAX IV, European
-
the platform by embedding/developing additional tools for data processing and analysis. The starting point for the developments will be our EasyNMR platform (see easynmr.pastis.dk ). Current application areas
-
interested in applicants with experience in either (i) high-performance magnetohydrodynamic simulations or (ii) the analysis and imaging of Very Long Baseline Interferometry data, but outstanding candidates
-
radiotherapy. Experience with photon-counting CT will be a considerable advantage. Deep learning knowledge will be an asset. CT image analysis skills is a prerequisite. You should have a strong theoretical
-
this position, we seek to strengthen the platform by embedding/developing additional tools for data processing and analysis. The starting point for the developments will be our EasyNMR platform (see